Link to article on Factset Insight: https://insight.factset.com/investors-and-traders-need-to-track-prescription-drug-user-fee-act-pdufa-content
Summary:
PDUFA dates and content are essential for portfolio managers of healthcare stocks. A single positive or negative announcement from the U.S. Food and Drug Administration (FDA) can send shares of a biotech firm soaring or turn a hot name quickly into a bear market.
Related Content
-
_thumb.png)
CEO Uncertainty Spikes After Improving Last Quarter
-
_thumb.png)
Earnings Season Heats Up, Spotting Two Unusual Reporting Dates in the Consumer Space
-
Data Minds - Triple Threat: Leveraging Data to Manage AI, ESG, and ETF Risks | April 11, 2024 [Recording Available]
-
_thumb.png)
Q1 2024 Earnings Preview: Will Reports be Good Enough to Turn Markets Positive?
-
[Podcast] Interactive Brokers: The Ins and Outs of Earnings Announcements
-
Pensions & Investments: U.S. companies increase buyback announcements
-
_thumb.png)
Shareholder Meetings in Focus as Earnings Season Begins
-
_thumb.png)
Q2 2024 Investor Conference & Events Highlights
-
_thumb.png)
Q1 2024 Buyback and Dividend Increases Point to Improving Corporate Sentiment
-
MoneyFM: US Markets Wrap: What's driving the sunny outlook of CEOs and investors?
